Some individuals dealing with metabolic health concerns (such as insulin resistance or markers of inflammation) who arent focused on weight loss may find this approach worth exploring with their provider
What is the beyond-use-date (BUD)
Cohort design, covariates, and outcomes This retrospective, propensity-score-matched cohort study included obese patients (BMI 27 kg/m) initiating Tirzepatide, Semaglutide, Phentermine/Topiramate, Naltrexone/Bupropion, or Phentermine from November 1, 2023, through April 31, 2025
No matter which brand you choose, oral and injectable semaglutide have a few differences
That dual-agonist approach is likely why tirzepatide consistently outperforms single-pathway GLP-1 therapies in clinical trials, explains Dr
Record the reconstitution date and concentration, then refrigerate at 28C (3646F) away from direct light